<DOC>
	<DOCNO>NCT00002811</DOCNO>
	<brief_summary>RATIONALE : Patients xeroderma pigmentosum likely develop skin lesion sun-affected area . These skin lesion , actinic keratoses , develop skin cancer . T4N5 liposome lotion may reduce actinic keratoses sun-induced skin damage patient xeroderma pigmentosum . PURPOSE : Randomized double-blinded phase III trial compare treatment use T4N5 liposome lotion treatment use placebo reduce actinic keratoses sun-induced skin damage patient xeroderma pigmentosum .</brief_summary>
	<brief_title>T4N5 Liposome Lotion Compared With Placebo Lotion Preventing Actinic Keratoses Patients With Xeroderma Pigmentosum</brief_title>
	<detailed_description>OBJECTIVES : I . Compare safety efficacy T4N5 liposome lotion vs. placebo lotion reduce incidence actinic keratoses protect ultraviolet skin damage patient xeroderma pigmentosum . OUTLINE : Randomized , double-blind study . Groups 6 patient randomly assign 2:1 ratio Arms I II , respectively . Arm I : Chemoprevention . Lotion compose T4 endonuclease V protein encapsulate liposome suspend phosphate-buffered saline hydrogel base , T4N5 Liposome Lotion , T4N5 . Arm II : Control . Liposomes suspend phosphate-buffered saline hydrogel base , Placebo , PLCB . PROJECTED ACCRUAL : 6-30 patient enter multicenter study .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Xeroderma Pigmentosum</mesh_term>
	<mesh_term>Ichthyosis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis xeroderma pigmentosum confirm unscheduled DNA synthesis assay At least one histologically confirm actinic keratosis All actinic keratoses remove prior treatment No associate syndromes , e.g. , Cockayne 's syndrome trichothiodystrophy PATIENT CHARACTERISTICS : Age : 1.66 60 Other : Good general health mental capacity No illegal drug use No pregnant nursing woman Negative pregnancy test require fertile woman Effective contraception require fertile woman PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>actinic keratosis</keyword>
</DOC>